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Objective: Asthma is common and commonly under-treated. Currently quality
indicators often do not provide specific directions for areas of improvement. This
work lays the foundation for a quality improvement initiative that provides practice-
specific feedback related directly to clinical activities completed for individual
patients with asthma.
Methods: Medical record review using a group of quality assessment elements
developed from previous medical record review studies of asthma care and the
NAEPP asthma care guidelines.
Results: For 500 school children ages 5–18 yr who made one or more asthma visits in
the year of interest, the frequency of daytime asthma symptoms were recorded in
54% of patients’ medical records at any time during a one-year period, while
nighttime symptom frequency was recorded in 33%. Only 12% of medical records
recorded any information on missed work, school or activity days. Nine percent
recorded information or acknowledged any asthma
’ ’
triggers’’. Asthma severity level
was documented in only an additional 4% of the children’s records. Most medical
records documented prescribed asthma medications and dosages (85%) but few
recorded the medications or dosages the patients were actually taking.
Conclusions: Many medical records do not include the basic clinical information
required to assess asthma severity, adherence to asthma therapy or the response to
therapy. This lack of information makes implementation of asthma care guidelines
impossible. Therefore, these measures may be useful baseline quality indicators to
begin the process of improving asthma care.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
287 2758; fax: +1 507 287 2722.
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Asthma is among the most common reasons for a
visit to a family physician, pediatrician or general
internist.1,2 Almost 25% of children are told they
have asthma at some time before age 183–5 and
3–5% of adults report needing asthma care each
year with another 5% reporting exercise-induced
asthma.1,6–13 The majority of the 11.9 million
annual asthma-related office visits are made to
primary care physicians.3,4,7,13–15
Asthma is associated with significant preventable
morbidity and perhaps preventable mortality.16–25
Many studies have assessed the potential for
decreasing preventable morbidity, the quality of
asthma care provided, and its congruence with
national asthma guidelines.20,21,26–34 Most of the
studies show that prescribed asthma therapy varies
significantly from that recommended in guidelines
but few studies can link the therapy or outcomes
data to the specific aspects of care delivered by the
primary care physician. Therefore, few studies can
link the currently used quality indicators with
specific recommendations for changes in physician
management for individual patients or for system
enhancements to solve quality deficiencies.30,35–39
For example, telling physicians that the ratio of
prescribed inhaled corticosteroids to short acting
beta agonists is
’ ’
too low’’ does little to suggest an
intervention for individual patient care or to
develop a system-based solution.40–43
Most funded and published asthma guideline
implementation programs are intensive, require
extensive investment of time and personnel, have
shown only limited sustainable improvement and
are often too expensive to use in routine prac-
tice.34,44,45 Therefore asthma remains an appro-
priate area for continued development of more
practical and affordable quality assessment mea-
sures that can be linked to quality improvement
programs.
This study reports on the development of a new
simple set of asthma quality of care measures that
are directly linked to the most basic clinical
activities performed during an asthma visit.46,47
Some of these activities such as patient’s adher-
ence to recommended medications48,49 have been
assessed previously. Others have not. The instru-
mental activities selected50–52 quantify the doc-
umentation of timing and frequency of asthma
related symptoms, activity limitations, and re-
sponse to medication use and are designed to
assess asthma care in any primary care office
practice. The results are discussed in the context
of asthma quality improvement activities, and ways
in which this set of asthma quality measures can belinked directly to changes in physician and office
practice to enhance the ability of the physician,
patient and family to care for asthma.Methods
This is a retrospective medical record review study
of a random sample of school-aged children whose
parents reported they had asthma on a school-
based asthma screening survey completed in
Rochester, MN and whose diagnosis was confirmed
by medical record review4,7 and a second random
sample of school-aged children who made an
asthma visit (code 493.xx) to a large HMO in New
Mexico during 2001.
Rochester, MN is a city of 90,000 within rural
Minnesota. The school children in this community
are 75% White non-Hispanic and 35% qualify for free
or reduced lunch programs. Albequrque, NM is a
larger city with a more diverse population including
about 25% Hispanic children and another 15% of
other racial groups. About 41% of the school
children in Albequerque qualify for free breakfast
or lunch programs (2000 Census data).
After approval from the Olmsted Medical Center,
the Mayo Clinic and Lovelace Foundation Institu-
tional Review Boards, the sample of children for
medical record review was selected. The Minnesota
population was a random sample of 250 of the 1018
eligible children aged 5–18 yr whose parents said
they had been told their child had asthma. The
method of identifying these eligible children and
the school-based study have been described else-
where.4 The New Mexico sample of 250 subjects
was a random sample of all children aged 5–18 yr
who made an asthma visit (code 493.44) to one of
the Lovelace Clinic sites in Albuquerque, New
Mexico during 2001. The sample of 250 was drawn
from 2342 eligible children.
The medical records for all of the children were
identified. In Minnesota, 3 of 250 children selected
had no medical records found in any clinic in
Rochester, MN. All of the New Mexico children had
medical records that could be reviewed. In addition
to collecting demographic data to confirm age,
gender and the prevalence of asthma, additional
medical record data were collected from each
clinic visit in which asthma care or control was
discussed in the medical visit note. Using all visits
from the period of January 1–December 31, 2000 in
Minnesota and January 1, and December 31, 2001 in
New Mexico, medical records were searched for the
documentation of asthma-related symptoms, se-
verity scores and lung function data in medical and
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Asthma symptoms were considered to be wheezing,
prolonged coughing, chest tightness, difficulty
breathing and use of or need to use a short-acting
beta agonist inhaler. Severity levels were consid-
ered documented if any comments were present
that stated mild, moderate or severe asthma or
intermittent or persistent asthma even if the
persistent asthma did not have any other modifiers
documented. Lung function data included either
peak flow values or spirometery entered into the
medical record for children over 8 years of age but
was considered necessary only in the year of
incident diagnosis.51,53,54 Additional information
related to other asthma-like diagnoses in the
medical record such as reactive airway disease
(RAD) or wheezy bronchitis, presence of a follow-up
visit after any emergency department visit or
hospitalization for asthma were collected since
the medical records of the two large clinics in
Olmsted County, MN include emergency depart-
ment and hospitalization data.
Asthma medications were defined as any short or
long acting beta agonist, inhaled corticosteroid,
leukotriene modifiers, theophyllines, and cromo-
glycates. Oral steroids required specific notation
that they were for asthma therapy.
Inter-rater reliability testing was done using
mock study records since it was not possible to
use the actual records of either site to do this
testing. Ten mock study records were developed by
one of the authors (BPY). The inter-rater reliabilityTable 1 Suggested quality indicators.
Frequency of daytime symptoms
Frequency of nighttime symptoms
Number of missed activity days
Severity score if none of the above are present
Triggers documented or allergy referral
Prescribed medications documented
Actual medications used documented
NON-urgent asthma visit
RAD or other non-asthma diagnosis used
PEF or spirometery in year of new asthma diagnoses
if patient over 8 years of age.
Table 2 Demographics of sample.
Minnesota N ¼ 247 n(%)
Boys 143 (58)
Girls 104 (42)
5–12 years of age 125 (51)
13–18 years of age 122 (99)was assessed for each category of data in Table 2.
All four data abstractors (2 RNs from each site)
reviewed the 10 mock records. The inter-rater
reliability was high with only 8 items of the 104
items reviewed being different. In each case 1 of
the 4 study nurses recorded a different response.
The most common difference was in the of
documentation of symptom frequency. In 5 in-
stances 1 of the nurses marked present when the
note stated a range of symptom days such as 1–4
per month or none to occasional. Each nurse also
abstracted 5 patients medical records on two
occasions. Only five entries of the 97 assessed were
different between the two assessments. The inter
and intra-rater reliability were considered excel-
lent for this tool.
Data were analyzed at the person rather than
visit level. For each item the information was
considered to present or absent based on the entire
year of visits. For example, if one of three asthma-
related visits during the year documented medica-
tions actually used then that element or item was
considered to be present. Calculations were simple
proportions of presence for each item in all
subjects whose charts were reviewed. The data
from the two communities were not different on
any value using w2 comparisons. To protect the
identity of the individual care sites, the data
were combined across care sites in Minnesota and
New Mexico. No more sophisticated analyses
were performed since this is a baseline observa-
tional study.Results
Of the 500 children in the sample, 59% ðn ¼ 295Þ
were boys. There were slightly more children in the
group p12 than those 13 years and older. This was
due to the greater number of younger children
identified from the visit records in New Mexico
(Table 2).
Of the 497 children with an available medical
record to review, 490 had an asthma-related visit in
the year of interest. In New Mexico all of the 250
children identified by clinic visits with a code ofNew Mexico N ¼ 250 n(%) Total N ¼ 497 n(%)
152 (61) 295 (59)
98 (39) 202 (41)
140 (56) 265 (53)
110 (44) 232 (47)
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children whose parents said they had made an
asthma-related visit had one or more asthma visits
identified and available for abstraction. Overall,
24% of the children ðn ¼ 118Þ with visits had one or
more visits during the year with an ICD-9 code of
493.xx but a written diagnosis of reactive airway
disease or RAD. Only one diagnosis of wheezy
bronchitis was found in this cohort. Of those 118
children with at least one written diagnosis of RAD,
67% ðn ¼ 79Þ also had a diagnosis of
’ ’
asthma’’ in a
visit previous to the
’ ’
RAD’’ visit.
Overall, 54% of the 490 children ðn ¼ 265Þ had
the frequency of daytime symptoms that recorded
with sufficient specificity to be able to use them for
severity assessment (Table 3). Another 10% had
notes stating
’ ’
occasional’’,
’ ’
sometimes’’ or
’ ’
fre-
quent’’ daytime symptoms. These were not suffi-
ciently specific to determine severity and were
included with the 36% of children with no doc-
umentation of daytime symptoms frequency. Night-
time symptoms were less commonly noted with 33%
of medical records ðn ¼ 162Þ documenting fre-
quency, another 5% stating nighttime symptoms
occurred
’ ’
once in a while’’ or
’ ’
sometimes’’.
Comments of
’ ’
patient doing well’’ or
’ ’
poorly’’
were not considered documentation of any type of
symptom frequency.
Only 12% of the charts ðn ¼ 59Þ had specific
documentation of the number of missed activity
days including missed school days. Nine percent of
the records ðn ¼ 44Þ commented on triggers,
usually discussing the ability to avoid triggers, or
concerns about triggers or evidence of a referral to
another physician for allergy evaluation.
The severity level was present in 4% ðn ¼ 8Þ of
medical records that included one or more visits for
asthma in the year of observation. Only 3 of these
medical records did not also have all of the data
necessary to complete a severity assessment.Table 3 Documentation frequencies.
Activity N (%)
Asthma visit 490 (99)
RAD diagnosis 118 (24)
Daytime symptoms 265 (54)
Nighttime symptoms 162 (33)
Missed activity days 59 (12)
Triggers documented 44 (9)
Medications prescribed documented 422 (85)
Actual medication use documented 74 (15)
Number and percent of medical records in which each
item was documented.Altogether 11% ðn ¼ 56Þ of medical records that had
either a severity score or sufficient data to develop
a severity scores. There were only 5 incident cases
of asthma in children 8 years and older among the
group studied. Of these 3 had a peak flow level
assessed or had spirometery testing recorded
ðn ¼ 2Þ. Peak flow testing was present in 48%
ðn ¼ 246Þ of the urgent care and emergency room
visits for asthma exacerbations.
A total of 11% of the children ðn ¼ 54Þ had at
least one non-urgent visit (not to urgent care or the
emergency department or to the office for an
exacerbation or
’ ’
attack’’) during which asthma
control or therapy or education was discussed.
These visits were often primarily for a school,
sports or camp physical examination to complete a
required form and asthma evaluation was included
during the visit. Visits related just to asthma
management (visits primarily for asthma but with-
out an exacerbation) were uncommon (2% of
children, n ¼ 4). Of the 68 children (14%) who had
an emergency department (ED) visit for their
asthma, about two-thirds (68%, n ¼ 46) had a
follow-up visit within two weeks after the ED visit.
Medications that were prescribed were recorded
with name, dose and frequency in 85% of the
medical records. However, only 15% ðn ¼ 74Þ had
any comment on how frequently the medications
were actually being taken.
It was not possible to distinguish whether
symptom, activity limitation and medication ques-
tions were answered by the child or the parent
when both were present during the visit. Seven of
the visits appeared to be with a child only. The
level of documentation of all variable was the same
for children of all ages.Discussion
Physicians and nurses often do not record sufficient
data to allow assessment of asthma severity using
the NAEPP/NHLBI national guidelines.51,52,54 In
addition, they do not consistently use the same
’ ’
word’’ for a diagnosis of asthma and not all
children with visits to a non-office site, specifically
the ED, have a follow-up visit. The tested asthma
quality indicators appear to identify areas ripe for
quality improvement.
Currently all national and international asthma
guidelines (such as those of the ACAAI or AAAI and
GINA) are based on those developed by the science
committee of the National Asthma Education and
Prevention Program (NAEPP) and published by
NHLBI.51,52,54 These guidelines are derived from
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committee’s interpretation of that evidence. The
1991 guidelines were the first to report the
empirically based asthma severity index reported
to be the first step in attempting to translate
asthma research into guidelines and patient care.
The empirically based severity index continues to
be the basis for all US asthma management guide-
lines.51,55,56 The asthma severity system is based on
the frequency of daytime symptoms, nighttime
symptoms, activity limitations and medications.
Failure to record these data in the medial record
makes implementation of the national and inter-
national asthma guidelines difficult if not impos-
sible. While not perfect, the empirical severity
index has provided some suggested structure to
asthma care.
The asthma guidelines assume that the necessary
symptom and activity limitation information is
being obtained and that severity scores are being
calculated.51 However, the wide spread and con-
sistent lack of either severity levels or symptom
frequency and activity limitation data found in this
study demonstrates an important gap in current
asthma care. While it is true that physicians and
other clinicians may collect these data and simply
fail to document them, the lack of this information
in the clinical record makes longitudinal guideline-
based asthma care difficult or impossible to
imagine since it is unlikely that a physician can
remember what they fail to document over days,
weeks or months.
Physicians list several barriers to incorporating
the asthma guidelines into practice including time,
relevance and knowledge.29,58–61 Doerschug and
colleagues reported that obtaining the information
to calculate the asthma severity score was the least
understood and most difficult to operationalize
portion of the 1997 NAEPP asthma guidelines. Less
than 63% of asthma specialists and 46% of primary
care physicians could appropriately score the
severity of asthma in patient vignettes. They
concluded that all physicians could benefit from
further training in the use of severity scoring and
applying treatment paradigms based on asthma
severity.58 That conclusion supports the basic
premise of this project, that physicians and
practices do not have functional systems to obtain
the information needed to assess asthma severity
or control. Physicians must find it difficult or
impossible to initiate, modify and monitor asthma
treatment based on the person’s symptoms, current
adherence to previously recommended therapy or
functional limitations.
Large managed care organizations and National
Council for Quality Assessment (NCQA) use auditand feedback to clinics and on some occasions to
individual providers or physicians to improve
asthma care.30,31,62–68 The feedback from the
audits seldom includes information on basic clinical
activities or specific recommended changes in
systems or practice activities.69–71 For example,
stating that a certain practice has lower rates of
inhaled corticosteroid use than other similar clinics
suggests no specific strategy to resolve the pro-
blem.68,72 Outcome or quality measures suggested
by the National Institute for Child HealthCare
Quality (NICHQ) are based on assumptions that
symptoms and activity scores are being routinely
collected.42 The NICHQ programs provide tools for
collecting symptom data but do make such data
collection a measured outcome. The marked lack of
documented symptom, activity and actual medica-
tion use in current primary care physicians records
suggests that quality measures that include assess-
ment of these basic clinical activities are important
intermediate steps before attempting to include
rates of severity assessment or appropriate medi-
cation ratios as quality measures.
For physicians who choose not to use the asthma
severity assessment as outlined in the NHLBI
guidelines54 it is difficult to imagine how a patient’s
current status can be assessed or how to determine
appropriate changes in medication can be devel-
oped without some metric related to symptoms.
Terms such as
’ ’
often’’,
’ ’
sometimes’’ or
’ ’
occa-
sionally’’ to describe the frequency of symptoms
may have very disparate meanings and are unlikely
to provide a reliable measure of control or response
to therapy.57 Few physicians would want to titrate
medications for angina or cholesterol management
based on such vague assessments.
Other quality indicators such as the consistent
use of terminology for asthma may also be
important. Parents report they have little con-
fidence in a health care system that interchange-
ably uses a variety of terms for their child’s
illness.57 Parents and adults with asthma report
that using alternative terminology such as RAD or
wheezy bronchitis suggests that the physician does
not really know whether or not they or their child
have asthma and makes giving or using chronic or
daily medication less attractive.57
This is a pilot study to assess the type of data that
can be obtained using simple quality measures
based on the basic elements of a patient history.
The available data is limited by the use of medical
records that often do not record all the information
obtained during a medical visit. However, the
recorded data is the information available for
longitudinal care and to other clinicians who may
care for the person in addition to the usual
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from only three large medical clinics and may not
reflect practice at other sites with limited racial
and ethnic variability. Therefore, this work should
be repeated in other settings across the country.Conclusions
Without having basic pieces of clinic data such as
symptom frequency, frequency of missed activities,
actual medications used and response to those
medications, current asthma care guidelines can-
not be used. Translating these necessary and
important data elements into quality measures
allows audits in which each measure has a direct
solution that can be incorporated into the care
system of a practice. Use of these simple clinical
activity items as quality assessment tools may
further facilitate translation of asthma guidelines
into practice. Additional research will be required
to assess the ability of changes in the quality
measures to affect patient outcomes.Acknowledgement
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